Veraxa Biotech AG - Post de-SPAC

VRXAWNasdaq Switzerland Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$14.127 M

$0.10 +22.88%

Close of 21 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Veraxa Biotech AG - Post de-SPAC lists more than one class of stock. Company figures above cover all classes combined.

VRXA

Where these numbers come from

Share counts and financials for Veraxa Biotech AG - Post de-SPAC are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 21 Aug 2026. Read the methodology.